Stereotactic Surgery Devices Market Analysis: Major Players, Lucrative Segments And Top Geographies
27 Jul, 2023
The global stereotactic surgery devices market size is expected to grow from $20.56 billion in 2022 to $21.43 billion in 2023 at a compound annual growth rate (CAGR) of 4.24%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global stereotactic surgery devices market size is expected to reach $25.67 billion in 2027 at a CAGR of 4.61%.
Global Stereotactic Surgery Devices Market Key Driver
The rising prevalence of Parkinson's disease and epilepsy is projected to drive the growth of the stereotactic surgical device market in the coming years. Parkinson's disease is a neurodegenerative disease that causes involuntary shaking, sluggish movement, and rigid, inflexible muscles, whereas epilepsy is a neurological condition that damages the brain and makes patients more prone to have periodic, unprovoked seizures. Stereotactic surgical devices are used to treat movement disorders, epilepsy, pain, psychiatry, and Parkinson's disease, among other things.
Get a sample of the global stereotactic surgery devices market reportGlobal Stereotactic Surgery Devices Market Segments
The global stereotactic surgery devices market is segmented:
1) By Product: Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam, CyberKnife
2) By Application: Brain Tumor Treatment, Arteriovenous Malformations Treatment, Parkinsons Disease, Epilepsy, Other Applications
3) By End User: Hospitals, Laboratories
4) By Geography: The regions covered in the stereotactic surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global stereotactic surgery devices market.
Major Stereotactic Surgery Devices Industry Players
Alliance Oncology, Micromar Industria Commercio Ltd., Adeor Medical AG, Monteris Medical, Inomed Medizintechnik Gmbh, IBA Proton Therapy, Elekta AB, Varian Medical Systems Inc., Accuracy Incorporated, Modus Medical Devices Inc., Koninklijke Philips N.V., Huiheng Group Co., Mitsubishi Heavy Industries Ltd., GE HealthCare Technologies Inc., Siemens Ag
Get the full global stereotactic surgery devices market report
Stereotactic Surgery Devices Market Overview
A stereotactic surgical device is a technology that employs a set of three coordinates to precisely locate brain parts while the head is in a fixed position. It is used in stereotactic surgery to implant things into the brain, such as medications or hormones.
Stereotactic Surgery Devices Global Market Report 2023 provides data on the global stereotactic surgery devices market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The stereotactic surgery devices market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.